Curium Pharma (India) Private Limited, a active private limited company, was established on 24 December 2004 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230MH2004PTC150212. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹10.30 Cr and a paid-up capital of ₹10.30 Cr.
It upholds a compliant status. Employing 26 professional, Its leadership includes Xavier Anne J Defourt (Director), Susamoy Mishra (Director), Krishna Chaitanya Tatineni (Director). Past directors included Olivier Jacques G Legrain, Xavier Anne J Defourt, Fazal Mahemood Kassam Ali Manekia. Its latest AGM occurred on 20 September 2024, with the balance sheet filed on 31 March 2024. It is based at 4/42, Tardeo A/C Market Building Tardeo Road, Mumbai, Maharashtra, 400034.
U24230MH2004PTC150212
150212
24 December 2004
₹10.30 Cr
₹10.30 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Curium Pharma (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Xavier Anne J Defourt | Director | 11 Nov 2020 | Current |
| Susamoy Mishra | Director | 26 Feb 2024 | Current |
| Krishna Chaitanya Tatineni | Director | 17 Feb 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 05 Aug 2010 | Past |
| Pramod Abcsdd | Additional Director | 18 Dec 2020 | Past |
| Pramod Abcsdd | Additional Director | 10 Sep 2009 | Past |
| Pramod Abcsdd | Additional Director | 19 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 20 Sep 2016 | Past |
| Pramod Abcsdd | Director | 15 Feb 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Curium Pharma (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 23.52% increase. The company also saw a substantial improvement in profitability, with a 54.63% increase in profit. The company's net worth Soared by an impressive increase of 22.81%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Curium Pharma (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Curium Pharma (India) has a workforce of 26 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Curium Pharma (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Curium Pharma (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Curium Pharma (India) Private Limited last Annual general meeting of members was held on 20 Sep 2024 as per latest MCA records. was recorded as a recent event.
Curium Pharma (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Susamoy Mishra was appointed as a Director was appointed as a Director on 26 Feb 2024 & has been associated with this company since 1 year 9 months . was recorded as a recent event.
Progress on Xavier Anne J Defourt was appointed as a Director was appointed as a Director on 11 Nov 2020 & has been associated with this company since 5 years 19 days . was documented.
Progress on Shikha Gupta was appointed as a Company Secretary was appointed as a Company Secretary on 22 Jun 2019 & has been associated with this company since 6 years 5 months . was documented.
Krishna Chaitanya Tatineni was appointed as a Director was appointed as a Director on 17 Feb 2018 & has been associated with this company since 7 years 9 months . was recorded as a recent event.
The CIN of Curium Pharma (India) Private Limited is U24230MH2004PTC150212.
Curium Pharma (India) Private Limited is headquartered at 4/42, Tardeo A/C Market Building Tardeo Road, Mumbai, Maharashtra, 400034.
Curium Pharma (India) Private Limited was incorporated on 24 December 2004.
The current directors of Curium Pharma (India) Private Limited are
The primary industry of Curium Pharma (India) Private Limited is Manufacturing.
Curium Pharma (India) Private Limited is unlisted.
The authorized capital of Curium Pharma (India) Private Limited is ₹10.30 Cr, and the paid-up capital is ₹10.30 Cr.
The compliance status of Curium Pharma (India) Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX